Endoscopic Ultrasonography and Magnetic Resonance Cholangiopancreatography in Abdominal Pain: What Makes Sense?

Diagnostic endoscopy (including gastroscopy and colonoscopy) and diagnostic endoscopic retrograde cholangiopancreatography (ERCP) have been facing severe challenges from other imaging modalities in recent years. Might diagnostic endoscopy and ERCP become obsolete? Are the new modalities accurate and cost-effective? Should training of endoscopists be focused on therapy? Recently, magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasonography (EUS) have been tested as investigation tools for abdominal pain. Does this make sense?

References

• 1 Barish M A, Yucel E K, Ferrucci J T. Magnetic resonance cholangiopancreatography.  N Engl J Med. 1999;  341 258-264
• 2 Liu T H, Consorti E T, Kawashima A, et al. The efficacy of magnetic resonance cholangiography for the evaluation of patients with suspected choledocholithiasis before laparoscopic cholecystectomy.  Am J Surg. 1999;  178 480-484
• 3 Varghese J C, Liddell R P, Farrell M A, et al. Diagnostic accuracy of magnetic resonance cholangiopancreatography in the detection of choledocholithiasis.  Clin Radiol. 2000;  55 25-35
• 4 Adamek H E, Albert J, Breer H, et al. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography.  Lancet. 2000;  356 190-193
• 5 Kim M J, Mitchell D G, Ito K, et al. Biliary dilatation: differentiation of benign from malignant causes: value of adding conventional MR imaging to MR cholangiopancreatography.  Radiology. 2000;  214 173-181
• 6 Farrell R J, Noonan N, Mahmud N, et al. Potential impact of MRCP on ERCP workload and complication rate in patients referred because of abdominal pain.  Endoscopy. 2001;  33 668-675
• 7 Booth-Clibborn N, Packer C, Stevens A. Health technology diffusion rates: statins, coronary stents and MRI in England.  Int J Technol Assess Health Care. 2000;  16 781-786
• 8 Baker L C. Managed care and technology adoption in health care: evidence from magnetic resonance imaging.  J Health Econ. 2001;  20 395-421
• 9 Talley N J, Stanghellini V, Heading R C, et al. Functional gastroduodenal disorders.  Gut. 1999;  45 Suppl 2 1137-1142
• 10 Amouyal P, Amouyal G, Levy P, et al. Diagnosis of choledocholithiasis by endoscopic ultrasonography.  Gastroenterology. 1994;  106 1062-1067
• 11 Palazzo L, Girollet P P, Salmeron M, et al. Value of endoscopic ultrasonography in the diagnosis of common bile duct stones: comparison with surgical exploration and ERCP.  Gastroint Endosc. 1995;  42 225-231
• 12 Rösch T, Braig C, Gain T, et al. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography.  Gastroenterology. 1992;  102 188-199
• 13 Yasuda K, Mukai H, Fujimoto S, et al. The diagnosis of pancreatic cancer by endoscopic ultrasonography.  Gastrointest Endosc. 1988;  34 1-8
• 14 Lees W R, Vallon A G, Denyer M E, et al. Prospective study of ultrasonography in chronic pancreatic disease.  Br Med J. 1979;  1 162-164
• 15 Wiersema M J, Hawes R H, Lehman G A, et al. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin.  Endoscopy. 1993;  25 555-564
• 16 Sahai A V, Penman I D, Mishra G, et al. An assessment of potential value of endoscopic ultrasound as a cost-minimizing tool in dyspepsia with persistent symptoms.  Endoscopy. 2001;  33 662-667
• 17 Sahai A V, Mishra G, Penman I D, et al. EUS to detect evidence of pancreatic disease in patients with persistent or nonspecific dyspepsia.  Gastrointest Endosc. 2000;  52 153-159
• 18 Wallace M B, Hawes R H, Durkalski V, et al. The reliability of EUS for the diagnosis of chronic pancreatitis: interobserver agreement among experienced endosonographers.  Gastrointest Endosc. 2001;  53 294-299